PMVP

PMV Pharmaceuticals, Inc. PMVP

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-18.09M

Quarter to Jun 30

Free cash flow

$-14.58M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$45.93M total
BML Capital Management, LLC
$7.14M+0.2%
TANG CAPITAL MANAGEMENT LLC
$5.69M0.0%
Sio Capital Management, LLC
$3.53M-14.4%
Euclidean Capital LLC
$3.52M0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$3.16M+26.9%
ACADIAN ASSET MANAGEMENT LLC
$2.97M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$2.70M+1.9%
ArrowMark Colorado Holdings LLC
$2.63M-31.8%
TWO SIGMA INVESTMENTS, LP
$2.62M+3.7%
Eversept Partners, LP
$2.53M-19.5%
BlackRock, Inc.
$1.23M+5.2%
Stonepine Capital Management, LLC
$718.4K-24.3%
GEODE CAPITAL MANAGEMENT, LLC
$634.6K-4.6%
Aldebaran Capital, LLC
$626.4K-1.3%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$574.7K0.0%
BIT Capital GmbH
$546.1K+229.9%
Verdad Advisers, LP
$485.6K+101.1%
Walleye Capital LLC
$449.8K0.0%
Assenagon Asset Management S.A.
$442.2K-8.5%
MARSHALL WACE, LLP
$431.0K-25.9%
VANGUARD FIDUCIARY TRUST CO
$341.4K-14.5%
BANK OF AMERICA CORP /DE/
$321.7K-0.2%
ADAR1 Capital Management, LLC
$269.4K-13.0%
STATE STREET CORP
$245.5K0.0%
RBF Capital, LLC
$217.3K0.0%
See all 64 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PMVP

Earnings Per Share

13fpro.ai/company/PMVP

Loading ratio trend…

PMVP insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About PMV Pharmaceuticals, Inc. (PMVP): stock profile, AI score and financials

PMV Pharmaceuticals, Inc. (PMVP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. PMVP is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), PMV Pharmaceuticals, Inc. reports net income of $-18.1M, free cash flow of $-14.6M. Top institutional holders of PMVP by reported 13-F value include BML Capital Management, TANG CAPITAL MANAGEMENT, Sio Capital Management, based on the most recent SEC filings. PMVP trades on the Nasdaq exchange and files with the SEC under CIK 1699382. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PMVP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PMV Pharmaceuticals, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1699382 →